Research programme: antibacterials - Quorex Pharmaceuticals

Drug Profile

Research programme: antibacterials - Quorex Pharmaceuticals

Alternative Names: QX5-1646 series antibacterials - Quorex; QX5-1799 series antibacterials - Quorex; QX5-1809 series antibacterials - Quorex

Latest Information Update: 25 May 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Quorex Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action DNA gyrase inhibitors; FabH inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 25 May 2010 No development reported - Preclinical for Bacterial infections in USA (unspecified route)
  • 12 Jul 2004 This programme is still in active development - BIO 2004 Annual International Convention (BIO-2004)
  • 30 Jan 2003 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top